[CLDX] QoQ Quarter Result on 30-Sep-2010 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
04-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- 4.60%
YoY- -26.67%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 1,952 2,516 37,721 2,408 2,951 3,713 4,733 -44.68%
PBT -9,802 -9,574 23,046 -8,755 -9,191 -6,245 -13,020 -17.28%
Tax -158 -268 1,449 -248 -190 -6,324 -159 -0.42%
NP -10,236 -10,059 22,661 -9,087 -9,525 -6,582 -12,943 -14.51%
Tax Rate - - -6.29% - - - - -
Total Cost 12,188 12,575 15,060 11,495 12,476 10,295 17,676 -22.00%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin -524.39 -399.80 60.08 -377.37 -322.77 -177.27 -273.46 54.53%
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
EPS -4.10 -4.71 10.61 -4.27 -4.49 -3.11 -6.13 -23.57%
EPS Diluted -4.10 -4.71 10.61 -4.27 -4.49 -3.11 -6.13 -23.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.